首页 | 本学科首页   官方微博 | 高级检索  
检索        


Pharmacokinetic/Pharmacodynamic Modellingof GnRH Antagonist Degarelix: A Comparisonof the Non-linear Mixed-Effects Programs NONMEM and NLME
Authors:Email author" target="_blank">Christoffer?W?Torn?eEmail author  Henrik?Agers?  Henrik?A?Nielsen  Henrik?Madsen  E?Niclas?Jonsson
Institution:(1) Experimental Medicine, Ferring Pharmaceuticals A/S, Kay Fiskers Plads 11, DK 2300 Copenhagen S, Denmark;(2) Informatics and Mathematical Modelling, Technical University of Denmark, Lyngby, Denmark;(3) Department of Pharmaceutical Biosciences, Division of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden
Abstract:In this paper, the two non-linear mixed-effects programs NONMEM and NLME were compared for their use in population pharmacokinetic/pharmacodynamic (PK/PD) modelling. We have described the first-order conditional estimation (FOCE) method as implemented in NONMEM and the alternating algorithm in NLME proposed by Lindstrom and Bates. The two programs were tested using clinical PK/PD data of a new gonadotropin-releasing hormone (GnRH) antagonist degarelix currently being developed for prostate cancer treatment. The pharmacokinetics of intravenous administered degarelix was analysed using a three compartment model while the pharmacodynamics was analysed using a turnover model with a pool compartment. The results indicated that the two algorithms produce consistent parameter estimates. The bias and precision of the two algorithms were further investigated using a parametric bootstrap procedure which showed that NONMEM produced more accurate results than NLME together with the nlmeODE package for this specific study.
Keywords:population pharmacokinetic/pharmacodynamic modelling  non-linear mixed-effects programs  NONMEM  NLME  degarelix  GnRH antagonist
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号